FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 25, 2007
Docket # Title
1992N-0391 Analysis of Adverse Reactions to Monosodium Glutamate (MSG)
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
1998P-0031 Protecting America from the consequences of tobacco products
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
2005N-0374 Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers
2005P-0293 Citizen Petition Regarding the Labeling of Vitamin A by Supplement Companies
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
2007D-0202 Guidance for Industry: Microbiological Considerations for
2007N-0262 Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
2007N-0264 Revisions to the Requirements Applicable to Blood, Blood Components and Source Plasma, Direct Final Rule
2007P-0085 Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
2007P-0210 Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
2007V-0360 Laser Light Show
1992N-0391 Analysis of Adverse Reactions to Monosodium Glutamate (MSG)
C 247 Carolyn Harris Vol #: 18
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
SUP 17 Chr. Hansen, Inc. Vol #: 327
1998P-0031 Protecting America from the consequences of tobacco products
C 3 Form Letter Count 39 Vol #: 1
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
CS 29 FDA/DDM Vol #: 245
OR 26 FDA/Administrative Law Judge Vol #: 245
2005N-0374 Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers
C 12 Thomas Burnside Vol #: 1
2005P-0293 Citizen Petition Regarding the Labeling of Vitamin A by Supplement Companies
C 1 Jean Heister Vol #: 1
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
C 2783 J Wood Vol #: 28
C 2784 J Palmer Vol #: 28
C 2785 M Neal Vol #: 28
C 2786 E Pecoraro Vol #: 28
C 2787 A Owens Vol #: 28
C 2788 P Garey Vol #: 28
C 2789 D Williams Vol #: 28
C 2790 B Pritchard Vol #: 28
C 2791 C Phillips Vol #: 28
C 2792 R Searles Vol #: 28
C 2793 N Ventura Vol #: 28
C 2794 O Jurey Vol #: 28
C 2795 R Blaine Vol #: 28
C 2796 W Hultman Vol #: 28
C 2797 M Peterson Vol #: 28
C 2798 S Leonard Vol #: 28
C 2799 S Ehm Vol #: 28
C 2800 L Wood Vol #: 28
C 2801 G Hardymon Vol #: 28
C 2802 M Friedman Vol #: 28
C 2803 D Davis Vol #: 28
C 2804 H Leveque Vol #: 28
C 2805 I Baumgardner Vol #: 28
C 2806 A Schl oz Vol #: 28
C 2807 R Arnold Vol #: 28
C 2808 D Huffman Vol #: 28
C 2809 A Richter Vol #: 28
C 2810 H Schallmo Vol #: 28
C 2811 D Donovan Vol #: 28
C 2812 R Stern Vol #: 28
C 2813 P Hensley Vol #: 28
C 2814 E Wallace Vol #: 28
C 2815 C Jeffrey Vol #: 28
C 2816 P Nagel Vol #: 28
C 2817 S Caldwell Vol #: 28
C 2818 W Sebastian Vol #: 28
C 2819 P Georgeson Vol #: 28
C 2820 I Glover Vol #: 28
C 2821 G Kohel Vol #: 28
C 2822 M Nolan Vol #: 28
C 2823 R Endeward Vol #: 28
C 2824 D Randall Vol #: 28
C 2825 R Greve Vol #: 28
C 2826 G Steven Vol #: 28
C 2827 R Marohn Vol #: 28
C 2828 M Frost Vol #: 28
C 2829 J hacker Vol #: 28
C 2830 V Sullivan Vol #: 28
C 2831 B Rubermer Vol #: 28
C 2832 C Schulte Vol #: 28
C 2833 C Mock Vol #: 28
C 2834 J Nehls Vol #: 28
C 2835 G Ceamak Vol #: 28
C 2836 J Baumeister Vol #: 28
C 2837 D Rubright Vol #: 28
C 2838 P Baade Vol #: 28
C 2839 L Matthews Vol #: 28
C 2840 S Denby Vol #: 28
C 2841 M Anderson Vol #: 28
C 2842 I Workley Vol #: 29
C 2843 J Krenik Vol #: 29
C 2844 L Ross Vol #: 29
C 2845 J Fisher Vol #: 29
C 2846 V Barney Vol #: 29
C 2847 B Collier Vol #: 29
C 2848 J Murphy Vol #: 29
C 2849 D Pilolla Vol #: 29
C 2850 R Whitaker Vol #: 29
C 2851 M Horton Vol #: 29
C 2852 I Friedman Vol #: 29
C 2853 J O'Donnell Vol #: 29
C 2854 N Wilson Vol #: 29
C 2855 J Florence Vol #: 29
C 2856 B Lerch Vol #: 29
C 2857 R Wegrzyn Vol #: 29
C 2858 L Stewart Vol #: 29
C 2859 C Thurn Vol #: 29
C 2860 M Rivera Vol #: 29
C 2861 B Gordon Vol #: 29
C 2862 C Wint Vol #: 29
C 2863 J McClelland Vol #: 29
C 2864 W Burton Vol #: 29
C 2865 M Dudley Vol #: 29
C 2866 S Cook Vol #: 29
C 2867 L Aman Vol #: 29
C 2868 M Bjornson Vol #: 29
C 2869 A Lysne Vol #: 29
C 2870 F Layer Vol #: 29
C 2871 C Weimer Vol #: 29
C 2872 R Suckley Vol #: 29
C 2873 B clark Vol #: 29
C 2874 M Strifler Vol #: 29
C 2875 L Davis Vol #: 29
C 2876 G Stortz Vol #: 29
C 2877 H Preiss Vol #: 29
C 2878 L Prindiville Vol #: 29
C 2879 B Schmisseur Vol #: 29
C 2880 G Perez Vol #: 29
C 2881 M Stock Vol #: 29
C 2882 P Leonard Vol #: 29
C 2883 J Wagner Vol #: 29
C 2884 B Honea Vol #: 29
C 2885 M Heaton Vol #: 29
C 2886 L Hildebrant Vol #: 29
C 2887 J Rogers Sr Vol #: 29
C 2888 Allergy & Asthma Care Vol #: 29
C 2889 D Hein Vol #: 29
C 2890 A Winch Vol #: 29
C 2891 B CLiff Vol #: 29
C 2892 M Russo Vol #: 29
C 2893 B Morris Vol #: 29
C 2894 E Weidenmoyer Vol #: 29
C 2895 D Gardner Vol #: 29
C 2896 M Kosciuk Vol #: 29
C 2897 J Underdown Vol #: 29
C 2898 L Bonini Vol #: 29
C 2899 R Jahnke Vol #: 29
C 2900 D Hennessy Vol #: 29
C 2901 D Smith Vol #: 29
C 2902 B Upin Vol #: 29
C 2903 W Boyle Vol #: 29
C 2904 J Cox Vol #: 29
C 2905 F Schlup Vol #: 29
C 2906 G Miller Vol #: 29
C 2907 M Grimes Vol #: 29
C 2908 J Bowman Jr Vol #: 29
C 2909 R Bailey Vol #: 29
C 2910 L Cornelsen Vol #: 29
C 2911 N Cummings Vol #: 29
C 2912 S Hidalgo Vol #: 29
C 2913 D Wooten Vol #: 29
C 2914 N Greer Vol #: 29
C 2915 D Backus Vol #: 29
C 2916 M Davis Vol #: 29
C 2917 F Yee Vol #: 29
C 2918 M Gallup Vol #: 29
C 2919 G Landes Vol #: 29
C 2920 P Daves Vol #: 29
C 2921 J Grigsby Vol #: 29
C 2922 G McCleary Vol #: 29
C 2923 I Wray Vol #: 29
C 2924 H Webb Sr Vol #: 29
C 2925 C Eagan Vol #: 29
C 2926 C Myers Vol #: 29
C 2927 M Walchak Vol #: 29
C 2928 R Zimmerman Vol #: 29
C 2929 M Burroughs Vol #: 29
C 2930 B Ellett Vol #: 29
C 2931 M Springer Vol #: 29
C 2932 C Glenn Vol #: 29
C 2933 H Prock Vol #: 29
C 2934 M Fox Vol #: 29
C 2935 D Katzen Vol #: 29
C 2936 S Storm Vol #: 29
C 2937 P Barentine Vol #: 29
C 2938 M Erlewine Vol #: 29
C 2939 J Adrianenssens Vol #: 29
C 2940 D Javurek Vol #: 29
C 2941 M Hocmann Vol #: 29
C 2942 R Horschmann Vol #: 29
C 2943 J Coody Vol #: 29
C 2944 M Lambert Vol #: 29
C 2945 J Baker Vol #: 29
C 2946 R Robbins Vol #: 29
C 2947 A Ostipow Vol #: 29
C 2948 B Vinson Vol #: 29
C 2949 S Giles Vol #: 29
C 2950 E Littlefor Vol #: 29
C 2951 J Rochester Vol #: 29
C 2952 E Thorn Vol #: 29
C 2953 l Jones Vol #: 29
C 2954 R Kelley Vol #: 29
C 2955 S Kimmelman Vol #: 29
C 2956 William A Schaffer Vol #: 29
C 2957 E Swider Vol #: 29
C 2958 J Dobbs Vol #: 29
C 2959 R Melbourne Vol #: 29
C 2960 P Blankenship Vol #: 29
C 2961 L Adams Vol #: 29
C 2962 M Ulrich Vol #: 29
2007D-0202 Guidance for Industry: Microbiological Considerations for
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2007N-0262 Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
EREG 1 b. sachau Vol #: 1
2007N-0264 Revisions to the Requirements Applicable to Blood, Blood Components and Source Plasma, Direct Final Rule
C 1 Rita Kamani Vol #: 1
2007P-0085 Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
C 314 Shelly Kellogg Vol #: 6
C 315 Theresa G. Martin Vol #: 6
C 316 Wilma M. Ahrens Vol #: 6
C 317 Ellen A. Morgan Vol #: 6
C 318 Bob Gerber Vol #: 6
C 319 Lorrie Maurer Vol #: 6
LET 1 Steven R. Mason Vol #: 6
2007P-0210 Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
C 1 Mercola.com Vol #: 1
2007V-0360 Laser Light Show
ACK 1 FDA/ DDM/ to Bel Entertainment LLC Vol #: 1
VAR 1 Bel Entertainment LLC Vol #: 1

Page created on September 25, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management